Multifunctional Serotonin Agonist Antagonists (MSAAs) are used to treat hypoactive sexual desire disorder (HSDD), or low libido, in premenopausal women. They work by correcting imbalances of some hormones responsible for sexual excitement, and decreasing levels of serotonin, responsible for sexual inhibition and satiety.
Medications for sexual arousal disorders (MSAAs) are used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. MSAAs work by affecting neurotransmitters in the brain or increasing blood flow to sexual organs, which helps improve sexual desire and performance. These medications come in different forms, including oral pills and topical applications. Examples include flibanserin (Addyi) for HSDD in women.
Addyi (flibanserin) is used to treat hypoactive (low) sexual desire disorder (HSDD) in both pre and postmenopausal women women (up to 65 years of age) who have not had low sexual desire in the past, and who have low sexual desire no matter the type of sexual activity, the situation, or the sexual partner.
GoodRx has partnered with InsideRx and Sprout Pharmaceuticals to reduce the price for this prescription. Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Addyi is not covered by most Medicare and insurance plans.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up